Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition

International Journal of Cardiology

Volumn 138, Issue 1, 2010, Pages 19-24

  Doehner, Wolfram ^a,b   Gathercole, David ^c   Cicoira, Mariantonietta ^b   Krack, Andreas ^d   Coats, Andrew J S ^b   Camici, Paolo G ^c   Anker, Stefan D ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Chronic heart failure; GLUT4; Insulin resistance; Metabolism; Skeletal muscle

Indexed keywords

GLUCOSE TRANSPORTER 4;

AGED; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; HEART FAILURE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; ISCHEMIC HEART DISEASE; MALE; MUSCLE BIOPSY; MUSCLE LEVEL; PRIORITY JOURNAL; SKELETAL MUSCLE; TISSUE DISTRIBUTION;

AGED; BIOPSY; BODY COMPOSITION; CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; DIABETES MELLITUS; ENERGY METABOLISM; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORTER TYPE 4; HEART FAILURE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PREDICTIVE VALUE OF TESTS; STROKE VOLUME;

EID: 70749131551     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.07.004     Document Type: Article

References (22)

1. De Sousa E., Veksler V., Bigard X., Mateo P., and Ventura-Clapier R. Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle. Circulation 102 (2000) 1847-1853
2. Wilson J.R., Mancini D.M., and Dunkman W.B. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation 87 (1993) 470-475
3. Swan J.W., Anker S.D., Walton C., et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 30 (1997) 527-532
4. Paolisso G., De Riu S., Marrazzo G., Verza M., Varricchio M., and D'Onofrio F. Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. Metabolism 40 (1991) 972-977
5. Doehner W., Rauchhaus M., Ponikowski P., et al. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 46 (2005) 1019-1026
6. DeFronzo R.A., Jacot E., Jequier E., Maeder E., Wahren J., and Felber J.P. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30 (1981) 1000-1007
7. Olson A.L., and Pessin J.E. Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annu Rev Nutr 16 (1996) 235-256
8. Cline G.W., Petersen K.F., Krssak M., et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341 (1999) 240-246
9. Kainulainen H., Breiner M., Schurmann A., Marttinen A., Virjo A., and Joost H.G. In vivo glucose uptake and glucose transporter proteins GLUT1 and GLUT4 in heart and various types of skeletal muscle from streptozotocin-diabetic rats. Biochim Biophys Acta 1225 (1994) 275-282
10. Paternostro G., Pagano D., Gnecchi-Ruscone T., Bonser R.S., and Camici P.G. Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res 42 (1999) 246-253
11. Murray A.J., Anderson R.E., Watson G.C., Radda G.K., and Clarke K. Uncoupling proteins in human heart. Lancet 364 (2004) 1786-1888
12. Doehner W., Rauchhaus M., Godsland I.F., et al. Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine and TNF-alpha. Int J Cardiol 83 (2002) 73-81
13. Opie L.H. The metabolic vicious cycle in heart failure. Lancet 364 (2004) 1733-1734
14. Coppen S.R., Dupont E., Rothery S., and Severs N.J. Connexin45 expression is preferentially associated with the ventricular conduction system in mouse and rat heart. Circ Res 82 (1998) 232-243
15. Swan J.W., Walton C., and Godsland I.F. Assessment of insulin sensitivity in man: a comparison of minimal model and euglycaemic clamp derived measures in health and heart failure. Clin Sci 86 (1994) 317-322
16. Doehner W., Anker S.D., and Godsland I.F. Optimizing insulin sensitivity assessment using the minimal model in chronic heart failure. Horm Metab Res 37 (2005) 106-110
17. Zisman A., Peroni O.D., Abel E.D., et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6 (2000) 924-928
18. Ryder J.W., Yang J., Galuska D., et al. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 49 (2000) 647-654
19. Hruz P.W., Yan Q., Struthers H., and Jay P.Y. HIV protease inhibitors that block GLUT4 precipitate acute, decompensated heart failure in a mouse model of dilated cardiomyopathy. FASEB J 22 (2008) 2161-2167
20. Swan J.W., Walton C., Godsland I.F., Clark A.L., Coats A.J.S., and Oliver M.F. Insulin resistance in chronic heart failure. Eur Heart J 15 (1994) 1528-1532
21. Lund S., Holman G.D., Schmitz O., and Pedersen O. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci U S A 92 (1995) 5817-5821
22. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150